FdaApplication
ANDA 204512
Identifiers
- fda_app_no: ANDA204512
Properties
| Property | Value |
|---|---|
| applicant_name | NCM USA BRONX LLC |
| application_type | ANDA |
| approval_date | 2015-01-07 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| FLUDEOXYGLUCOSE F18 | FLUDEOXYGLUCOSE F-18 | 20-300mCi/ML | INJECTABLE;INTRAVENOUS |
1 product